For the readers interested in the stock health of Agenus Inc. (AGEN). It is currently valued at $5.40. When the transactions were called off in the previous session, Stock hit the highs of $5.75, after setting-off with the price of $5.68. Company’s stock value dipped to $5.335 during the trading on the day. When the trading was stopped its value was $5.64.Recently in News on October 12, 2021, Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific Antibody. Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced it has triggered the first development milestone payment under its global licensing agreement with Bristol Myers Squibb for AGEN1777, an Fc-enhanced bispecific anti-TIGIT antibody. Agenus will receive a $20 million cash payment with the dosing of the first patient. You can read further details here
Agenus Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.79 on 08/30/21, with the lowest value was $2.50 for the same time period, recorded on 04/20/21.
Agenus Inc. (AGEN) full year performance was 20.27%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Agenus Inc. shares are logging -20.47% during the 52-week period from high price, and 116.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.50 and $6.79.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2678494 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Agenus Inc. (AGEN) recorded performance in the market was 69.81%, having the revenues showcasing 0.00% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.26B, as it employees total of 359 workers.
Market experts do have their say about Agenus Inc. (AGEN)
During the last month, 2 analysts gave the Agenus Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.49, with a change in the price was noted +1.21. In a similar fashion, Agenus Inc. posted a movement of +28.88% for the period of last 100 days, recording 3,672,577 in trading volumes.
Technical breakdown of Agenus Inc. (AGEN)
Raw Stochastic average of Agenus Inc. in the period of last 50 days is set at 16.77%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.05%. In the last 20 days, the company’s Stochastic %K was 39.91% and its Stochastic %D was recorded 42.53%.
Bearing in mind the latest performance of Agenus Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 69.81%. Additionally, trading for the stock in the period of the last six months notably improved by 103.01%, alongside a boost of 20.27% for the period of the last 12 months. The shares increased approximately by -4.26% in the 7-day charts and went down by -3.40% in the period of the last 30 days. Common stock shares were lifted by 0.00% during last recorded quarter.